Rapid progression of adult T-cell leukemia–lymphoma after PD-1 inhibitor therapy

Lee Ratner, Thomas A. Waldmann, Murali Janakiram, Jonathan E. Brammer

Research output: Contribution to journalLetter

30 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1947-1948
Number of pages2
JournalNew England Journal of Medicine
Volume378
Issue number20
DOIs
StatePublished - May 17 2018
Externally publishedYes

Fingerprint

Adult T Cell Leukemia Lymphoma
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rapid progression of adult T-cell leukemia–lymphoma after PD-1 inhibitor therapy. / Ratner, Lee; Waldmann, Thomas A.; Janakiram, Murali; Brammer, Jonathan E.

In: New England Journal of Medicine, Vol. 378, No. 20, 17.05.2018, p. 1947-1948.

Research output: Contribution to journalLetter

Ratner, Lee ; Waldmann, Thomas A. ; Janakiram, Murali ; Brammer, Jonathan E. / Rapid progression of adult T-cell leukemia–lymphoma after PD-1 inhibitor therapy. In: New England Journal of Medicine. 2018 ; Vol. 378, No. 20. pp. 1947-1948.
@article{f115ec42989743e8a9841ae472eaa844,
title = "Rapid progression of adult T-cell leukemia–lymphoma after PD-1 inhibitor therapy",
author = "Lee Ratner and Waldmann, {Thomas A.} and Murali Janakiram and Brammer, {Jonathan E.}",
year = "2018",
month = "5",
day = "17",
doi = "10.1056/NEJMc1803181",
language = "English (US)",
volume = "378",
pages = "1947--1948",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "20",

}

TY - JOUR

T1 - Rapid progression of adult T-cell leukemia–lymphoma after PD-1 inhibitor therapy

AU - Ratner, Lee

AU - Waldmann, Thomas A.

AU - Janakiram, Murali

AU - Brammer, Jonathan E.

PY - 2018/5/17

Y1 - 2018/5/17

UR - http://www.scopus.com/inward/record.url?scp=85047177942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047177942&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1803181

DO - 10.1056/NEJMc1803181

M3 - Letter

C2 - 29768155

AN - SCOPUS:85047177942

VL - 378

SP - 1947

EP - 1948

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 20

ER -